Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sophia Zoungas

Showing results (1-10 of 298) with videos related to

Pageof 30
Sort By:
Diabetes, Obesity & Metabolism|April 7, 2020
ADVANCE in context: The benefits, risks and feasibility of providing intensive glycaemic control based on gliclazide modified releaseSophia Zoungas
Annals of the New York Academy of Sciences|November 25, 2010
Cardiovascular outcomes in type 2 diabetes: the impact of preventative therapiesSophia Zoungas, Anushka Patel
Nature Reviews. Cardiology|April 20, 2011
Diabetes. Insights from the extended follow-up of the ACCORD trialSophia Zoungas, Mark Woodward
Evidence-Based Medicine|November 4, 2017
Intensive glucose control in patients with diabetes prevents onset and progression of microalbuminuria, but effects on end-stage kidney disease are still uncertainClement Lo, Sophia Zoungas
Journal of Hypertension|August 30, 2019
The modulating effect of differences in cardiovascular risk factors on major cardiovascular outcomes in glucose-lowering trials: 'good to know' but not the whole storyDanijela Gasevic, Sophia Zoungas
Evidence-Based Medicine|December 1, 2011
Intensive glucose-lowering therapy in people with type 2 diabetes: what do we learn from a new meta-analysis of randomised controlled trials?Fiona Turnbull, Sophia Zoungas
Nature Reviews. Nephrology|February 8, 2012
Diabetes: glycemic control and outcomes in people with diabetes and CKDSophia Zoungas, John Chalmers
Evidence-Based Medicine|August 31, 2012
Intensive glucose control in patients with type 2 diabetes is associated with a reduction in albuminuria and may be associated with reduced end-stage renal diseaseClement Lo, Sophia Zoungas
Evidence-Based Nursing|March 8, 2024
Remission of type 2 diabetes is achievable in primary care with intensive lifestyle interventionSophia Zoungas, Priya Sumithran
Clinical and Experimental Pharmacology & Physiology|June 22, 2007
Arterial stiffness and cardiovascular outcomeSophia Zoungas, Roland P Asmar
Pageof 30

Showing results (1-10 of 298) with videos related to

Sort By:
Pageof 30
Diabetes, Obesity & Metabolism|April 7, 2020
ADVANCE in context: The benefits, risks and feasibility of providing intensive glycaemic control based on gliclazide modified releaseSophia Zoungas
Annals of the New York Academy of Sciences|November 25, 2010
Cardiovascular outcomes in type 2 diabetes: the impact of preventative therapiesSophia Zoungas, Anushka Patel
Nature Reviews. Cardiology|April 20, 2011
Diabetes. Insights from the extended follow-up of the ACCORD trialSophia Zoungas, Mark Woodward
Evidence-Based Medicine|November 4, 2017
Intensive glucose control in patients with diabetes prevents onset and progression of microalbuminuria, but effects on end-stage kidney disease are still uncertainClement Lo, Sophia Zoungas
Journal of Hypertension|August 30, 2019
The modulating effect of differences in cardiovascular risk factors on major cardiovascular outcomes in glucose-lowering trials: 'good to know' but not the whole storyDanijela Gasevic, Sophia Zoungas
Evidence-Based Medicine|December 1, 2011
Intensive glucose-lowering therapy in people with type 2 diabetes: what do we learn from a new meta-analysis of randomised controlled trials?Fiona Turnbull, Sophia Zoungas
Nature Reviews. Nephrology|February 8, 2012
Diabetes: glycemic control and outcomes in people with diabetes and CKDSophia Zoungas, John Chalmers
Evidence-Based Medicine|August 31, 2012
Intensive glucose control in patients with type 2 diabetes is associated with a reduction in albuminuria and may be associated with reduced end-stage renal diseaseClement Lo, Sophia Zoungas
Evidence-Based Nursing|March 8, 2024
Remission of type 2 diabetes is achievable in primary care with intensive lifestyle interventionSophia Zoungas, Priya Sumithran
Clinical and Experimental Pharmacology & Physiology|June 22, 2007
Arterial stiffness and cardiovascular outcomeSophia Zoungas, Roland P Asmar
Pageof 30